OOIR: Observatory of International Research

Papers

(The H4-Index of Radiation Oncology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent	62
Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial	61
Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer	57
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)	57
Correction to: 125I seeds irradiation inhibits tumor growth and induces apoptosis by Ki-67, P21, survivin, livin and caspase-9 expression in lung carcinoma xenografts	52
Efficacy and safety of tyrosine kinase inhibitors with thoracic radiotherapy for patients with oncogene-mutated non-small cell lung cancer: a meta-analysis	47
Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy	44
Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study	42
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov	41
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma	40
Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer	39
Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prost	36
Evaluating differences in respiratory motion estimates during radiotherapy: a single planning 4DMRI versus daily 4DMRI	35
Radiotherapy refusal in breast cancer with breast-conserving surgery	34
The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review	33
Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia	33
A multifunctional targeted nano-delivery system with radiosensitization and immune activation in glioblastoma	32
Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer	31
Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis	31
Using meta-analysis and CNN-NLP to review and classify the medical literature for normal tissue complication probability in head and neck cancer	30
125I seed brachytherapy for non-central pelvic recurrence of cervical cancer after external beam radiotherapy	30
Compliance of volunteers in a fully-enclosed patient rotation system for MR-guided radiation therapy: a prospective study	30
Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors	30
CircRNA_101491 regulated the radiation sensitivity of esophageal squamous cell carcinomas via sponging miR-125a-5p	29
Comparison of deep learning networks for fully automated head and neck tumor delineation on multi-centric PET/CT images	29

CT-based auto-segmentation of multiple target volumes for all-in-one radiotherapy in rectal cancer patients	28
A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy	28
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma	27
Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with	27
Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc th	27